CAS: 1125780-41-7 - SKLB610
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SKLB 610 REF: AN-AG008TJJCAS: 1125780-41-7 | 98% | 79.00 €~183.00 € | Tue 21 May 24 |
 | SKLB 610 REF: TM-T1895CAS: 1125780-41-7 | 99.30% | 36.00 €~1,006.00 € | Tue 28 May 24 |
 | SKLB 610 REF: 3D-FS100095CAS: 1125780-41-7 | Min. 95% | To inquire | Tue 02 Jul 24 |
SKLB 610
CAS:1125780-41-7
Formula:
C21H16F3N3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
415.3652
Ref: AN-AG008TJJ
| 5mg | 183.00 € | |
| 10mg | 79.00 € | |
| 25mg | 104.00 € | |
| 50mg | 145.00 € | |
| 100mg | 167.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
SKLB 610
CAS:1125780-41-7
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a …
Formula:
C21H16F3N3O3
Purity:
99.30%
Color and Shape:
Solid
Molecular weight:
415.37
Ref: TM-T1895
| 1mg | 36.00 € | |
| 5mg | 69.00 € | |
| 10mg | 119.00 € | |
| 25mg | 218.00 € | |
| 50mg | 322.00 € | |
| 100mg | 476.00 € | |
| 200mg | 677.00 € | |
| 500mg | 1,006.00 € | |
| 1ml*10 (DMSO) | 104.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
SKLB 610
CAS:1125780-41-7
SKLB 610 is a potential anticancer agent that inhibits tumor growth. SKLB 610 has shown …
Formula:
C21H16F3N3O3
Purity:
Min. 95%
Molecular weight:
415.37 g/mol
Ref: 3D-FS100095
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
